Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

GHK-Cu Cosmetic Dosage Protocol Guide: Research Application Comparison

Different research objectives require different dosing approaches. The table below compares standard protocols by target tissue, concentration range, and application method used in peer-reviewed dermatological studies. Whole-face collagen remodeling 0.05%–0.5%

This source-based comparison does not add ratings or recommend a winner.

  • Different research objectives require different dosing approaches. The table below compares standard protocols by target tissue, concentration range, and application method used in peer-reviewed dermatological studies.
  • Whole-face collagen remodeling
  • 0.05%–0.5% (0.5–5mg/mL)
  • Twice daily
  • Chemical enhancer (5% propylene glycol) or liposomal carrier
  • 1–2mg per full-face application
  • 12–24 weeks
  • Best for systemic skin density improvement; requires consistent long-term application; lower irritation risk
  • Periorbital wrinkle reduction
  • 0.5%–1% (5–10mg/mL)
  • Once daily (evening)
  • Liposomal carrier or light microneedling (0.25mm)
  • 0.5–1mg per periorbital area
  • 8–16 weeks
  • Targets thin skin areas; microneedling depth must remain shallow to avoid bruising; results visible by week 6–8
  • Acne scar revision
  • 1%–2% (10–20mg/mL)
  • Three times weekly
  • Microneedling 0.5–1.0mm depth
  • 2–3mg per treatment area (50cm²)
  • 12–20 weeks
  • Requires physical penetration for dermal remodeling; improvement plateaus after 16–18 weeks; maintenance dosing extends results
  • Surgical scar treatment
  • 2%–3% (20–30mg/mL)
  • Daily for 4 weeks, then every other day
  • Direct application post-microneedling (1.0mm)
  • 3–5mg per 10cm² scar tissue
  • 8–12 weeks
  • High-concentration protocols show fastest remodeling; risk of irritation increases above 2.5%; combine with silicone occlusion for best outcome
  • Wound healing acceleration
  • 1.5%–2.5% (15–25mg/mL)
  • Twice daily until epithelialization complete
  • Direct application to wound bed (non-infected)
  • 2–4mg per wound area
  • Until closure (typically 2–4 weeks)
  • GHK-Cu shows anti-inflammatory and pro-healing effects; discontinue if signs of infection appear; not a replacement for standard wound care
  • The comparison shows concentration and frequency are both concentration-dependent and objective-dependent. Whole-face protocols use lower concentrations over larger areas for longer durations. Localized scar protocols concentrate higher doses into small treatment zones for shorter, more intense remodeling windows. Our experience working with research teams shows the biggest mistake is applying whole-face concentrations to scar tissue—you won't get meaningful remodeling at 0.1% when the target is dense fibrotic tissue. Match your concentration to your tissue target.